Skin manifestations of arthropod-borne infection in Latin America

Current Opinion in Infectious Diseases

Volumn 27, Issue 3, 2014, Pages 288-294

  Bolivar Mejia, Adrián ^a   Alarcón Olave, Camila ^b   Rodriguez Morales, Alfonso J ^c,d  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

^c UNIVERSIDAD TECNOLÓGICA DE PEREIRA   (Colombia)

^d Working Group on Zoonoses   (United Kingdom)

Author keywords

arthropod borne infection; epidemiology; Latin America; skin manifestations

Indexed keywords

AEDES AEGYPTI; AMERICAN LEISHMANIASIS; ANGIONEUROTIC EDEMA; ARTHROPOD; ARTHROPOD BORNE DISEASE; CARRION DISEASE; CHAGAS DISEASE; CHAGOMA; CHRONIC DISEASE; CONJUNCTIVITIS; DENGUE; DEPIGMENTATION; ECCHYMOSIS; EPISTAXIS; ERYTHEMA; FACE ERYTHEMA; FEVER; FURUNCULOSIS; GANGRENE; GEOGRAPHIC DISTRIBUTION; HEMOLYTIC ANEMIA; HUMAN; INFECTION; INSECT BITE; JAUNDICE; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LICHENIFIED ONCHODERMATITIS; LICHENOID ERUPTION; LUTZOMYIA; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALARIA; MEASLES LIKE RASH; NONHUMAN; ONCHOCERCIASIS; ORAL BLEEDING; PALLOR; PANNICULITIS; PAPULE; PARASITE TRANSMISSION; PERIORBITAL EDEMA; PETECHIA; PHLEBOTOMUS; PREAURICULAR LYMPHADENOPATHY; PURPURA; RASH; REVIEW; ROMANA SIGN; SKIN ATROPHY; SKIN EDEMA; SKIN LEISHMANIASIS; SKIN MANIFESTATION; SKIN NECROSIS; SKIN NODULE; SKIN PRURITUS; SKIN SWELLING; SKIN ULCER; SOFT PALATE; SOUTH AND CENTRAL AMERICA; SUBCUTANEOUS NODULE; URTICARIA; VISCERAL LEISHMANIASIS; YELLOW FEVER; ANIMAL; BARTONELLA INFECTIONS; CLIMATE CHANGE; INTERNATIONAL COOPERATION; LEISHMANIASIS; MICROBIOLOGY; PARASITOLOGY; PATHOLOGY; PUBLIC HEALTH; SKIN; SKIN DISEASES, PARASITIC;

ANIMALS; BARTONELLA INFECTIONS; CLIMATE CHANGE; HUMANS; INTERNATIONALITY; LATIN AMERICA; LEISHMANIASIS; ONCHOCERCIASIS; PUBLIC HEALTH; SKIN; SKIN DISEASES, PARASITIC;

EID: 84900499781     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000060     Document Type: Review

References (82)

1. Dujardin J-C, Herrera S, do Rosario V, et al. Research priorities for neglected infectious diseases in Latin America and the Caribbean Region. PLoS Negl Trop Dis 2010; 4:e780.
2. Gubler D. Vector-borne diseases. Rev Sci Tech Off Int Epizoot 2009; 28:583-588.
3. Cardenas R, Sandoval CM, Rodriguez-Morales AJ, Franco-Paredes C. Impact of climate variability in the occurrence of leishmaniasis in Northeastern Colombia. Am J Trop Med Hyg 2006; 75:273-277.
4. Goddard J, Edwards KT. Effects of bed bug saliva on human skin. JAMA Dermatol 2013; 149:372-373.
5. Velez ID, Carrillo LM, Lopez L, et al. An epidemic outbreak of canine cutaneous leishmaniasis in Colombia caused by Leishmania braziliensis and Leishmania panamensis. Am J Trop Med Hyg 2012; 86:807-811.
6. Delgado O, Silva S, Coraspe V, et al. American cutaneous leishmaniasis in children and adolescents from north central Venezuela. Trop Biomed 2008; 25:178-183.
7. Stockdale L, Newton R. A review of preventive methods against human leishmaniasis infection. PLoS Negl Trop Dis 2013; 7:e2278.
8. Reveiz L, Silveira AN, Elkhoury M, et al. Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update. PLoS One 2013; 8:e61843.
9. Fontes-Alves C, Figueiredo M, Carvalho C, et al. American tegumentary leishmaniasis: effectiveness of an immunohistochemical protocol for the detection of leishmania in skin. PLoS One 2013; 8:e63343.
10. Gama ME, Gomes CM, Silveira FT, et al. Severe visceral leishmaniasis in children: the relationship between cytokine patterns and clinical features. Rev Soc Bras Med Trop 2013; 46:741-745.
11. Dantas ML, Oliveira JC, Carvalho L, et al. CD8+ T cells in situ in different clinical forms of human cutaneous leishmaniasis. Rev Soc Bras Med Trop 2013; 46:728-734.
12. Bacon KM, Hotez PJ, Kruchten SD, et al. The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. Vaccine 2013; 31:480-486.
13. Bari AU. Clinical spectrum of cutaneous leishmaniasis: an overview from Pakistan. Dermatol Online J 2012; 18:4.
14. Rezvan H. Immunogenicity of HLA-DR1 restricted peptides derived from Leishmania major gp63 using FVB/N-DR1 transgenic mouse model. Iran J Parasitol 2013; 8:273-279.
15. Olliaro P, Vaillant M, Arana B, et al. Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis 2013; 7:e2130.
16. de Paulo LF, Rocha GF, Luisi CM Jr, et al. Mucocutaneous leishmaniasis: mucosal manifestations in an endemic country. Int J Infect Dis 2013; 17:e1088-e1089.
17. Blazes DL, Mullins K, Smoak BL, et al. Novel Bartonella agent as cause of verruga peruana. Emerg Infect Dis 2013; 19:1111-1114.
18. Seas C, Villaverde H, Maguina C. Images in clinical tropical medicine: a 60-year-old man from the highlands of Peru with fever and hemolysis. Am J Trop Med Hyg 2012; 86:381.
19. Sanchez Clemente N, Ugarte-Gil CA, Soló rzano N, et al. Bartonella bacilli-formis: a systematic review of the literature to guide the research agenda for elimination. PLoS Negl Trop Dis 2012; 6:e1819.
20. Maguiña C, Guerra H, Ventosilla P. Bartonellosis. Clin Dermatol 2009;27:271-280.
21. Prutsky G, Domecq JP, Mori L, et al. Treatment outcomes of human barto-nellosis: a systematic review and meta-analysis. Int J Infect Dis 2013;17:e811-e819.
22. Pachas E. Epidemiology of Carrion's disease in Perú. Lima 2000; 2000:1-83.
23. Maguiña C, Cok J, Gilman R, et al. Prospective study of recurrent peruvian wart. Dermatol Peru 2003; 13:189-194.
24. Llerena Luna C, Schweig Groisman M, Ugarte-Gil CA. Knowledges, attitudes and practice on Carrion's disease in the rural population of Anchash, Peru. Rev Panam Salud Publica 2013; 33:311-315.
25. Saettone-Leon A. Peruvian wart. Dermatol Peru 2004; 14:121-133.
26. Ibérico T, Ballona R, Cáceres H, et al. Peruvian wart: compromise of mucosa. Literature review. Folia Dermatológica Peruana 1996; 7:55-58.
27. Haro D, Tobaru L, Guzmán M. Ocular manifestations of Carrion's disease. Folia Dermatol Peru 2008; 19:9-14.
28. Carrion's disease: Peru 2013. National network of epidemiology (RENACE)-DGE-MINSA. Hasta la SE 44. Peru, 2013.
29. Maguina C, Garcia PJ, Gotuzzo E, et al. Bartonellosis (Carrió n's disease) in the modern era. Clin Infect Dis 2001; 33:772-779.
30. Maco V, Maguiña C, Tirado A, et al. Carrion's disease (Bartonellosis bacilli-formis) confirmed by histopathology in the high forest of Peru. Rev Inst Med Trop Sao Paulo 2004; 46:171-174.
31. Mullins KE, Hang J, Jiang J, et al. Molecular typing of 'Candidatus Bartonella ancashi, ' a new human pathogen causing verruga peruana. J Clin Microbiol 2013; 51:3865-3868.
32. Amano Y, Rumbea J, Knobloch J, et al. Bartonellosis in Ecuador: serosurvey and current statusofcutaneous verrucous disease. Am J Trop Med Hyg 1997; 57:174-179.
33. Centers for Disease Control and Prevention (CDC). Progress toward elimination of onchocerciasis in the Americas: 1993-2012. MMWR Morb Mortal Wkly Rep 2013; 62:405-408.
34. WHO. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec 2013; 88:381-385.
35. Murdoch ME. Onchodermatitis. Curr Opin Infect Dis 2010; 23:124-131.
36. Dori GU, Belay T, Belete H, et al. Parasitological and clinico-epidemiological features of onchocerciasis in West Wellega Ethiopia. J Parasit Dis 2012; 36:10-18.
37. Díaz-Mené ndez M, Norman F, Monge-Maillo B, et al. Filariasis in the clinical practice. Enferm Infecc Microbiol Clin 2011; 29 (Supl 5): 27-37.
38. Mattar S, Morales V, Cassab A, Rodríguez-Morales AJ. Effect of climate variables on dengue incidence in a tropical Caribbean municipality of Colombia, Cerete, 2003-2008. Int J Infect Dis 2013; 17:e358-e359.
39. Branco MD, Luna EJ, Braga LL, Júnior LLB, et al. Risk factors associated with death in Brazilian children with severe dengue: a case-control study. Clinics (Sao Paulo) 2014; 69:55-60.
40. Teixeira MG, Siqueira JB Jr, Ferreira GL, et al. Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. PLoS Negl Trop Dis 2013; 7:e2520.
41. Pires NR, Sá SL, Pinho SC, et al. Dengue infection in children and adolescents: clinical profile in a reference hospital in northeast Brazil. Rev Soc Bras Med Trop 2013; 46:765-768.
42. Quintero J, Brochero H, Manrique-Saide P, et al. Ecological, biological and social dimensions of dengue vector breeding in five urban settings of Latin America: a multi-country study. BMC Infect Dis 2014; 14:38.
43. Pontes FS, Frances LT, Carvalho MD, et al. Severe oral manifestation of dengue viral infection: a rare clinical description. Quintessence Int 2014; 45:151-156.
44. Pun SB, Shah Y. Critical phase among patients with dengue fever during the 2010 outbreak in Nepal. Trans R Soc Trop Med Hyg 2013; 107:598-600.
45. Thomas EA, John M, Kanish B. Mucocutaneous manifestations of Dengue fever. Indian J Dermatol 2010; 55:79-85.
46. Namvongsa V, Sirivichayakul C, Songsithichok S, et al. Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health 2013; 44:772-779.
47. Lupi O, Tyring S. Tropical dermatology: viral tropical diseases. J Am Acad Dermatol 2003; 49:979-1000.
48. Rifakis PM, Benitez JA, De-la-Paz-Pineda J, Rodriguez-Morales AJ. Epizootics of yellow fever in Venezuela (2004-2005): an emerging zoonotic disease. Ann N Y Acad Sci 2006; 1081:57-60.
49. Chavez E. Tropical diseases in Bolivia: yellow fever and dengue. Rev Soc Bol Ped 2007; 46:36-45.
50. Quaresma JA, Pagliari C, Medeiros DB, et al. Immunity and immune response, pathology and pathologic changes: progress and challenges in the immuno-pathology of yellow fever. Rev Med Virol 2013; 23:305-318.
51. Thomas M, Christopher G, Eitzen E. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol 1999; 135:311-322.
52. Filippis AM, Nogueira RM, Schatzmayr HG, et al. Outbreak of jaundice and hemorrhagic fever in the Southeast of Brazil in 2001: detection and molecular characterization of yellow fever virus. J Med Virol 2002; 68:620-627.
53. Hidron A, Vogenthaler N, Santos-Preciado JI, et al. Cardiac involvement with parasitic infections. Clin Microbiol Rev 2010; 23:324-349.
54. Benitez JA, Araujo B, Contreras K, et al. Urban outbreak of acute orally acquired Chagas disease in Táchira, Venezuela. J Infect Dev Ctries 2013; 7:638-641.
55. Ramos JM, Torrús D, Amador C, et al. Multicenter epidemiological and clinical study on imported Chagas diseases in Alicante, Spain. Pathog Glob Health 2012; 106:340-345.
56. Franco-Paredes C, Jacob JT, Hidron A, et al. Transplantation and tropical infectious diseases. Int J Infect Dis 2010; 14:e189-e196.
57. Hemmige V, Tanowitz H, Sethi A. Trypanosoma cruzi infection: a review with emphasis on cutaneous manifestations. Int J Dermatol 2012; 51:501-508.
58. Amato JG, Amato Neto V, Amato VS, et al. Cutaneous lesions as the only manifestations of reactions to Trypanosoma cruzi infection in a recipient of a kidney transplant. Rev Soc Bras Med Trop 1996; 30:61-63.
59. Riganti J, Maqueda MG, Piñero MC, et al. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients. Int J Dermatol 2012; 51:829-834.
60. Altclas J, Sinagra A, Jaimovich G, et al. Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful preemptive therapy with benznidazole. Transpl Infect Dis 1999; 1:135-137.
61. Gallerano V, Consigli J, Pereyra S, et al. Chagas' disease reactivation with skin symptoms in a patient with kidney transplant. Int J Dermatol 2007; 46:607-610.
62. Antinori S, Galimberti L, Milazzo L, Corbellino M. Plasmodium knowlesi: the emerging zoonotic malaria parasite. Acta Trop 2013; 125:191-201.
63. López G, García C, Moreno L, et al. Malaria in developing countries. J Infect Dev Ctries 2014; 8:1-4.
64. Rodríguez-Morales AJ, Sánchez E, Vargas M, et al. Anemia and thrombocy-topenia in children with Plasmodium vivax malaria. J Trop Pediatr 2006; 52:49-51.
65. Rodriguez-Morales AJ, Sanchez E, Vargas M, et al. Pregnancy outcomes associated with Plasmodium vivax malaria in northeastern Venezuela. Am J Trop Med Hyg 2006; 74:755-757.
66. Laishram D, Sutton P, Nanda N, et al. The complexities of malaria disease manifestations with a focus on asymptomatic malaria. Malaria J 2012; 11:29.
67. Zaki S, Shanbag P. Plasmodium vivax malaria presenting with skin rash: a case report. J Vector Borne Dis 2011; 48:245-246.
68. Vaishnani JB. Cutaneous findings in five cases of malaria. Indian J Dermatol Venereol Leprol 2011; 77:110.
69. Sharma V, Singhal M, Sharma A, Kumar V. Febrile urticaria in a family: uncommon manifestation of a common disease. J Infect Dev Ctries 2012; 6:895-896.
70. Cressey BD, Paniz-Mondolfi AE, Rodríguez-Morales AJ, et al. Dermatitis linearis: vesicating dermatosis caused by Paederus species (Coleoptera: Staphylinidae). Case series and review. Wilderness Environ Med 2013; 24:124-131.
71. Rodriguez-Morales AJ, Arria M, Rojas-Mirabal J, et al. Lepidopterism due to exposure to the moth Hylesia metabus in northeastern Venezuela. Am J Trop Med Hyg 2005; 73:991-993.
72. Galletti B, Mannella VK, Santoro R, et al. Ear, nose and throat (ENT) involvement in zoonotic diseases: a systematic review. J Infect Dev Ctries 2014; 8:17-23.
73. Franco-Paredes C, Dismukes R, Nicolls D, et al. Persistent and untreated tropical infectious diseases among Sudanese refugees in the United States. Am J Trop Med Hyg 2007; 77:633-635.
74. Martins-Melo FR, Ramos AN Jr, Alencar CH, Heukelbach J. Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis. Acta Trop 2014; 130:167-174.
75. Weinkopff T, de Oliveira CI, de Carvalho AM, et al. Repeated exposure to Lutzomyia intermedia sand fly saliva induces local expression of interferon-inducible genes both at the site of injection in mice and in human blood. PLoS Negl Trop Dis 2014; 8:e2627.
76. Valderrama A, Tavares MG, Filho JD. Phylogeography of the Lutzomyia gomezi (Diptera: Phlebotominae) on the Panama Isthmus. Parasit Vectors 2014; 7:9.
77. González C, Paz A, Ferro C. Predicted altitudinal shifts and reduced spatial distribution of Leishmania infantum vector species under climate change scenarios in Colombia. Acta Trop 2014; 129:83-90.
78. Strasen J, Williams T, Ertl G, et al. Epidemiology of Chagas disease in Europe: many calculations, little knowledge. Clin Res Cardiol 2014; 103:1-10
79. Stoddard ST, Forshey BM, Morrison AC, et al. House-to-house human movement drives dengue virus transmission. Proc Natl Acad Sci, U S A 2013; 110:994-999.
80. Pérez-Molina JA. Management of Trypanosoma cruzi coinfection in HIV-positive individuals outside endemic areas. Curr Opin Infect Dis 2014; 27:9-15.
81. Jarvis JN, Lockwood DN. Clinical aspects of visceral leishmaniasis in HIV infection. Curr Opin Infect Dis 2013; 26:1-9.
82. Roberts CH, Mongkolsapaya J, Screaton G. New opportunities for control of dengue virus. Curr Opin Infect Dis 2013; 26:567-574.